Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Uveal Melanoma
Related studies linked through entity extraction aliases.
Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects
- Status
- RECRUITING
- Phase
- N/A
Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver
- Status
- RECRUITING
- Phase
- NA
Adding IL-2 to Tebentafusp to Eradicate Cancer Progression
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Neoadjuvant Darovasertib in Primary Uveal Melanoma
- Status
- RECRUITING
- Phase
- PHASE3
Adjuvant Quisinostat in High-Risk Uveal Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
- Status
- RECRUITING
- Phase
- PHASE1
A Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma
- Status
- RECRUITING
- Phase
- NA
PHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver Metastases
- Status
- RECRUITING
- Phase
- PHASE3
Uveal Melanoma - Comparative Study
- Status
- RECRUITING
- Phase
- N/A
Longitudinal Follow-Up of Patients Treated With Hypofractionated Stereotactic Photon Radiotherapy Due to Uveal Melanoma
- Status
- RECRUITING
- Phase
- N/A
Adjuvant Tebentafusp in High Risk Ocular Melanoma
- Status
- RECRUITING
- Phase
- PHASE3
Psychoeducation for Uveal Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Patient Experience and Quality of Life During the Surveillance Phase of Uveal Melanoma: A Prospective Multi-method Study
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
- Status
- RECRUITING
- Phase
- PHASE3
(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Melphalan Chemoreduction for Ocular Melanoma
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1/PHASE2